"When I was first contacted by
With more than two decades of experience in the world of marketing, Gunning is a master of developing sales and marketing strategies for Fortune 500 companies. As one of the original employees at
Gunning has also served as the Managing Director of RESQWATER™, a post workout recovery beverage designed to replenish nutrients and flush toxins, where he has helped guide the brand to exceed target goals in its sales and marketing program. Most recently, Gunning has served as a consultant for the hemp-derived cannabinoid company called Blue Sky Biologicals to manage a plethora of product SKUs under Blue Sky's brand, KANABIA™, where he was responsible for overseeing and developing all strategic marketing initiatives.
In his new role as CMO, Gunning will be responsible to help turn Mydecine into a household name and grow it into a stand-alone brand where clients and consumers can develop engagement, trust, and loyalty through engaging programs that deliver value propositions in mental health and wellness solutions utilizing the vast options of medicinal fungal compounds. One of Gunning's initial duties as CMO will be to develop a marketing campaign around Mydecine's new fungtional™ mushroom product line which should be on retail shelves across the
"I believe in the very near-term future fungi is going to play a far more significant role in our daily lives than we can ever imagine," added Gunning. "There are so many diverse applications to fungi that are in the classically defined "emerging" category of development; from health and beauty products, to meat alternatives, sustainable packaging, environmental remediation to even fashion."
Further, the Company announces the resignation of Mr.
Ben will be transitioning to an executive role within the Company's 50% owned distribution company,
About
For further information about
On Behalf of the Board of Directors:
Joshua Bartch
Chief Executive Officer
contact@mydecineinc.com
Corp Communication:
corp@mydecineinc.com
(250) 488-6728
Public Relations:
pr@mydecineinc.com
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, but not limited to completion of planned improvements at both the Canadian and US sites on schedule and on budget, the availability of financing needed to complete the Company's planned improvements on commercially reasonable terms, planned occupancy by the tenant-growers, commencement of operations, differences in yield on expected harvests, delays in obtaining statutory approval for marijuana production plans, issues that may arise throughout the grow period, outdoor crops affected by weather, the ability to mitigate the risk of loss through appropriate insurance policies, and the risks presented by federal statutes that may contradict local and state legislation respecting legalized marijuana. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
This news release does not constitute an offer of securities for sale in
View original content:http://www.prnewswire.com/news-releases/mydecine-innovations-group-inc-appoints-previous-red-bull-sports-marketing-director-jim-gunning-as-cmo-301099628.html
SOURCE
© Canada Newswire, source